Effect of long-term losartan administration on renal haemodynamics and function in hypertensive patients (original) (raw)
Efficacy and Tolerability of Losartan in Hypertensive Patients With Renal Impairment
Leopoldo Raij
Hypertension, 1998
View PDFchevron_right
Efficacy and safety of losartan in hypertensive patients with side effects induced by other antihypertensive agents
roberto giovannetti
Current Therapeutic Research, 1997
View PDFchevron_right
Effect of Losartan on Different Biochemical Parameters in Essential Hypertensive Patients
Chitra Khanwelkar
Biomedical and Pharmacology Journal, 2019
View PDFchevron_right
Tolerability and Antihypertensive Efficacy of Losartan vs Captopril in Patients with Mild to Moderate Hypertension and Impaired Renal Function
Jesper Nørgaard Bech
Clinical Drug Investigation, 2000
View PDFchevron_right
Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension
Jaime Perez Barragan
Clinical Therapeutics, 2000
View PDFchevron_right
Tolerability and Antihypertensive Efficacy of Losartan vs Captopril in Patients with Mild to Moderate Hypertension and Impaired Renal Function: A Randomised, Double-Blind, Parallel Study
Mauricio Ruiz
Clinical Drug Investigation, 2000
View PDFchevron_right
The antiproteinuric effect of losartan is systemic blood pressure dependent
Graham Kemp
Nephrology Dialysis Transplantation, 2003
View PDFchevron_right
Effect of losartan on ambulatory short-term blood pressure variability and cardiovascular remodeling in hypertensive patients on hemodialysis
Yoshiyuki Toya
Atherosclerosis, 2009
View PDFchevron_right
Efficacy of Losartan in the management of Post-Dialysis Euvolemic Hypertension (HELD-Trial): A Single-Blind Randomized Control Trial
Amer Khan
Scientific Reports, 2016
View PDFchevron_right
Safety and Efficacy of Losartan 50 mg in Reducing Blood Pressure among Patients with Post-Dialysis Euvolemic Hypertension: A Randomized Control Trial
Azreen Adnan
Scientific reports, 2017
View PDFchevron_right
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
William Keane
New England Journal of Medicine, 2001
View PDFchevron_right
Efficacy and safety of losartan in the treatment of hypertension in renal transplant recipients
Juan Jimenez Bravo
Kidney International, 1998
View PDFchevron_right
Efficacy and tolerability of losartan potassium and atenolol in patients with mild to moderate essential hypertension*
Lukas Makris
American Journal of Hypertension, 1995
View PDFchevron_right
Effect of Experimental Renal Failure on the Pharmacokinetics of Losartan in Rats
Masato Yasuhara
Biological Pharmaceutical Bulletin, 2002
View PDFchevron_right
Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers
T. Bjornsson
Hypertension, 1993
View PDFchevron_right
Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients
Chun-peng Liu
Heart and Vessels, 2004
View PDFchevron_right
A double-blind, dose-response study of losartan in hypertensive children
Francisco Cano
American journal of hypertension, 2005
View PDFchevron_right
The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study Group
Thomas Wilson
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1998
View PDFchevron_right
Comparative Efficacy of Olmesartan, Losartan, Valsartan, and Irbesartan in the Control of Essential Hypertension
David Williams
The Journal of Clinical Hypertension, 2001
View PDFchevron_right
Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial
Yuriy Sirenko
Vascular Health and Risk Management, 2013
View PDFchevron_right
LIFE (losartan intervention for endpoint reduction in hypertension) study and its substudies
Sibel Ertek
International Congress Series, 2007
View PDFchevron_right
Efficacy, safety, and effects on hypertension-associated symptoms of losartan, alone or in combination with hydrochlorothiazide, versus amlodipine in patients with mild-to-moderate hypertension
Manfred Stapff
Current Therapeutic Research, 1998
View PDFchevron_right
Comparative effects of chronic ACE inhibition and AT1 receptor blocked losartan on cardiac hypertrophy and renal function in hypertensive patients
Maria Leonarda De Rosa
Journal of Human Hypertension, 2002
View PDFchevron_right
Renal effects of losartan and amlodipine in hypertensive patients with non-diabetic nephropathy
Anders Hartmann
Nephrology Dialysis Transplantation, 1998
View PDFchevron_right
Evaluation of antihypertensive efficacy of Losartan + Hydrochlorthiazide versus Telmisartan + Hydrochlorthiazide in patients with stage 1 or stage 2 hypertension: a randomized controlled trial
Vijay Bajaj
International Journal of Basic & Clinical Pharmacology, 2018
View PDFchevron_right
Reduced progression of adriamycin nephropathy in spontaneously hypertensive rats treated by losartan
Jelica Grujic
Nephrology Dialysis Transplantation, 2008
View PDFchevron_right
Renal eVects of losartan and amlodipine in hypertensive patients with non-diabetic nephropathy
Anders Hartmann
1998
View PDFchevron_right
Comparison of Losartan and Enalapril Effects on Renal Function in Hypertensive Adults with Chronic Kidney Disease at a Kenyan Referral Hospital
Moses Mwangi
East African Medical Journal, 2014
View PDFchevron_right
Effects of losartan on hypertension and left ventricular mass: a long-term study
Giuseppe Limongelli
Journal of Human Hypertension, 1998
View PDFchevron_right
Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial
Peter F Kokkinos
Circulation, 2004
View PDFchevron_right